Cryoglobulinemia

Disease Description (Causes and Symptoms)

• Definition: Cryoglobulinemia is a condition in which blood proteins (cryoglobulins) precipitate and aggregate when body temperature drops, causing abnormalities within blood vessels.
• Classification:
  • Type I: Monoclonal (usually a single IgM or IgG), mainly associated with hematologic malignancies (multiple myeloma, chronic lymphocytic leukemia, etc.).
  • Type II (mixed): Monoclonal IgM (often with rheumatoid factor activity) + polyclonal IgG. Mainly associated with chronic infections (especially hepatitis C) or lymphoproliferative disorders.
  • Type III: Polyclonal IgM + polyclonal IgG, commonly occurring in autoimmune and infectious diseases.
• Main pathophysiology: Immune-complex deposition and complement activation cause small-vessel inflammation (small-vessel vasculitis) and/or vascular occlusion and hyperviscosity caused by monoclonal proteins.
• Representative symptoms:
  • Skin: Purpura (especially on the lower extremities), skin necrosis and ulcers, cyanosis, Raynaud phenomenon, livedo reticularis
  • Systemic/joints: Arthralgia, arthritis, generalized fatigue
  • Nervous system: Symmetric peripheral neuropathy (paresthesia, pain)
  • Kidneys: Glomerulonephritis (proteinuria, hematuria, decreased kidney function)
  • Hematologic: Symptoms of hyperviscosity (headache, visual disturbances) — mainly a concern in type I
• Associated diseases: Strong association with chronic hepatitis C (HCV), hepatitis B and hepatitis A, lymphoma, multiple myeloma, chronic lymphocytic leukemia, autoimmune diseases, etc.
• Tests helpful for diagnosis: Detection of cryoglobulins (cryocrit), decreased complement (C4), elevated rheumatoid factor (mixed types), serum protein electrophoresis and immunofixation, HCV/HBV testing, kidney biopsy (when suspected), etc.

Treatment (Standard Treatment, Medications·Procedures·Lifestyle Management, Precautions)

• General principles: Treat the underlying disease (e.g., HCV or a hematologic malignancy) first, and combine immunosuppression and plasma exchange depending on the severity of symptoms and organ involvement. Avoidance of cold exposure and skin protection are important.
• Main treatments by cause:
  • HCV-related mixed type: Direct-acting antiviral (DAA)-based antiviral treatment is first-line. Symptoms often improve when the virus is eradicated.
  • Hepatitis B/HBV-associated: Appropriate antiviral treatment (as directed by a liver specialist).
  • Type I (monoclonal): Treatment of the underlying hematologic disease (such as lymphoma or myeloma), including chemotherapy and targeted therapy, takes priority; plasmapheresis may be considered in cases of hyperviscosity or acute ischemia.
• Treatment for acute or organ-threatening disease (kidney involvement, peripheral necrosis, severe peripheral neuropathy, hyperviscosity syndrome):
  • Combination treatment with high-dose steroids (IV/oral) + rituximab (anti-CD20) is effective for severe vasculitis in mixed types.
  • Immunosuppressants such as cyclophosphamide and azathioprine (when the response to steroids is insufficient).
  • Plasma exchange: Temporarily effective in acute vascular occlusion, severe hyperviscosity, and life-threatening tissue ischemia.
• Symptom relief and supportive care: NSAIDs (for mild arthralgia), wound and ulcer care, pain control, and kidney treatment (such as dialysis) when kidney function worsens
• Lifestyle management and precautions:
  • Avoid cold, particularly exposure of peripheral areas such as the hands and feet, and keep warm (gloves, warm clothing, etc.).
  • Immunosuppressive treatment increases the risk of infection → vaccination (under a doctor’s direction) and immediate medical attention if symptoms of infection occur.
  • Regular blood tests (blood cell counts, liver function, kidney function) and monitoring of complement and cryocrit are recommended.
  • Seek emergency medical care in the event of clinical deterioration (necrosis, acute decrease in kidney function, visual disturbances, etc.).
• Risks of side effects and complications: Immunosuppressants (infection, bone marrow suppression), anticancer drugs (nausea, bone marrow toxicity), plasmapheresis (infection, electrolyte abnormalities), etc.

Checklist Before an Outpatient Visit (Including Example Questions)

• Items and test records to bring:
  • List of currently used medications and supplements (exact names and doses)
  • Previous medical certificates and blood tests, and hepatitis (HCV/HBV) test results (test reports if possible)
  • Recent urinalysis results (proteinuria, hematuria) and kidney function test results (if available)
  • Previous hematologic test results (serum protein electrophoresis, immunofixation, etc.) and biopsy results (if available)
  • Symptom diary (when symptoms occurred, relationship to cold exposure, patterns of worsening and improvement, photos of the skin)
• Information to tell the medical staff in advance during the outpatient visit:
  • When the symptoms began and how they have progressed (when and where they started, aggravating factors)
  • Associated symptoms such as fever, weight changes, bleeding or bruising, visual changes, and urinary abnormalities
  • History and family history of liver disease, malignancy, and autoimmune disease
• Example questions (items for patients to prepare themselves before the outpatient visit):
  • “Please record the date when the symptoms first began and the circumstances in which they started.”
  • “What symptoms occur when you are exposed to cold? (Pain/pallor/cyanosis/ulcers, etc.)”
  • “Have you recently noticed any changes in urine color or urination?”

General Example Questions to Ask the Doctor

• What is the cause of this disease, and what is the cause in my case (e.g., HCV, hematologic malignancy, etc.)?
• What initial treatment do you recommend for me (antiviral, immunosuppressive, or anticancer treatment), and what are the expected effects and duration?
• What are the main side effects of the proposed medication, and what symptoms should be monitored?
• What precautions or vaccinations (e.g., influenza or pneumococcal vaccination) are needed to prevent infection during treatment?
• If kidney or nerve symptoms worsen, when should I go to the emergency room?

Examples of Disease-Specific Questions

• If HCV association is suspected: “In my case, how likely are skin, nerve, and kidney symptoms to improve with antiviral (DAA) treatment? What additional tests are needed before and during treatment?”
• If monoclonal disease (type I) is suspected: “Are additional tests for blood cancer (multiple myeloma, lymphoma, etc.), such as a bone marrow examination or whole-body imaging, needed? If there is a risk of hyperviscosity or acute ischemia, what treatment would you provide first?”

(If necessary, please consult the relevant department about the list of tests to receive during the outpatient visit and the priorities for testing and treatment.)